Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by Reedyk41on Oct 24, 2019 7:14am

70 Views

Post# 30262998

If Kaly is dead, then why are you still here? Lol

Whether or not you have shares, I couldn’t care less about anymore. But why are you still here if Kaly is dead? Lol are you the chosen one who has come to warn us? I personally think you’re a fuking loser who lives for the Stockhouse bullboard. Good luck in life friend but I’ll be keeping my shares. Whether or not the company does well has nothing to do with you and your posts are absolute dog s#it.

Happy Thursday everyone!

- B

Bullboard Posts

Record Q3: Equinox Gold achieves commercial production at Greenstone Mine